Abbott today announced positive early results from a study evaluating its investigational Amulet 360 left atrial appendage ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Rates of patency and device-related thrombus were ...
In the showdown between left atrial appendage (LAA) closure devices, the Amplatzer Amulet outperformed Watchman for peridevice leaks (PDL) in one trial longer term but not in another. At 12 months of ...
Medical Device Network on MSN
Abbott reports positive VERITAS study results for AFib
VERITAS involved 400 patients at 34 sites across Europe, Canada, and the US.
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
On the basis of outcomes, there was no clear winner from a trial that directly compared two modern devices used in patients undergoing percutaneous left atrial appendage (LAA) closure. But the devices ...
Boston Scientific Corp. and Abbott Laboratories continue to parry over clinical trials comparing the latter’s Amplatzer Amulet with Boston Scientific’s Watchman in sealing the heart’s left atrial ...
Abbott’s Amplatzer Amulet Left Atrial Appendage Occluder was approved nearly two years ago. Here are five things to know about the minimally invasive device: 1. The product closes the left atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results